Clinical Report: Association of Vitamin C with Enhanced Prognosis in Patients Experiencing Myocardial Injury Due to Sepsis

Overview

This study investigates the association between vitamin C administration and prognosis in patients with sepsis-induced myocardial injury (SIMI) using the MIMIC-IV database. Findings suggest that vitamin C may improve outcomes in this high-risk population, highlighting its potential role in clinical management.

Background

Sepsis is a leading cause of mortality in intensive care units, often resulting in multiple organ dysfunction syndrome (MODS). Among its complications, sepsis-induced myocardial injury (SIMI) poses significant risks, with high in-hospital mortality rates. Understanding the role of adjunctive therapies like vitamin C in improving outcomes for SIMI patients is critical for enhancing treatment strategies.

Data Highlights

No specific numerical data was provided in the source material.

Key Findings

• Sepsis-induced myocardial injury (SIMI) has a high incidence and poor prognosis, with in-hospital mortality rates around 35%.
• Vitamin C administration has shown potential benefits in improving organ function and reducing inflammation in septic patients.
• Previous studies indicate a negative correlation between low plasma vitamin C levels and the incidence of multiple organ failure in sepsis patients.
• High-dose vitamin C may reduce the need for vasopressors in septic shock, although results are mixed regarding overall mortality benefits.
• Current guidelines suggest caution in the use of intravenous vitamin C for sepsis due to inconsistent evidence of efficacy.

Clinical Implications

Clinicians should consider the potential role of vitamin C as an adjunctive therapy in managing patients with SIMI, particularly given the high mortality associated with this condition. However, careful evaluation of the risks and benefits is essential, as current evidence remains inconclusive.

Conclusion

The findings from this study underscore the need for further research into vitamin C's role in improving outcomes for patients with SIMI, which could inform future clinical guidelines and treatment protocols.

References

1. Intensive Care Medicine, 2021 -- Impact of Combined Vitamin C, Glucocorticoids, and Vitamin B1 on Long-Term Mortality in Adults Experiencing Sepsis or Septic Shock: A Systematic Review and Component Network Meta-Analysis
2. Critical Care (Springer), 2025 -- Sodium ascorbate versus ascorbic acid in sepsis: a narrative review of emerging cardiovascular and neurological benefits
3. Intensive Care Medicine, 2018 -- Adjuvant Vitamin Supplementation in Critically Ill Patients: Emphasis on Thiamine, Vitamin C, and Vitamin D
4. Surviving Sepsis Campaign Adult Guidelines | SCCM, 2026
5. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network
6. Early high-sensitivity troponin elevation and short-term mortality in sepsis: a systematic review with meta-analysis
7. Clinical Research in Cardiology — Forecasting MRI-identified microvascular obstruction and its long-term consequences following acute myocardial infarction
8. Surviving Sepsis Campaign Adult Guidelines | SCCM
9. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network
10. Early high-sensitivity troponin elevation and short-term mortality in sepsis: a systematic review with meta-analysis